|
| 37645841 | DifferentialRegulation: a Bayesian hierarchical approach to identify differentially regulated genes. | bioRxiv | 2024 |
| 36893943 | Impact of COVID-19 on diagnosis of tuberculosis, multidrug-resistant tuberculosis, and on mortality in 11 countries in Europe, Northern America, and Australia. A Global Tuberculosis Network study. | Int J Infect Dis | 2023 |
| 37749839 | Clinical standards for diagnosis, treatment and prevention of post-COVID-19 lung disease. | Int J Tuberc Lung Dis | 2023 |
| 37749840 | Literature Highlights. | Int J Tuberc Lung Dis | 2023 |
| 37542087 | Efficacy of three antimicrobial mouthwashes in reducing SARS-CoV-2 viral load in the saliva of hospitalized patients: a randomized controlled pilot study. | Sci Rep | 2023 |
| 37679219 | Vaccination in post-tuberculosis lung disease management: A review of the evidence. | Pulmonology | 2023 |
| 37353868 | Clinical standards for the management of adverse effects during treatment for TB. | Int J Tuberc Lung Dis | 2023 |
| 37231605 | Literature Highlights. | Int J Tuberc Lung Dis | 2023 |
| 36855043 | Post-TB bronchiectasis: from pathogenesis to rehabilitation. | Int J Tuberc Lung Dis | 2023 |
| 36853105 | Literature Highlights. | Int J Tuberc Lung Dis | 2023 |
| 36918080 | Update of drug-resistant tuberculosis treatment guidelines: A turning point. | Int J Infect Dis | 2023 |
| 36495456 | A Guide to Trajectory Inference and RNA Velocity. | Methods Mol Biol | 2023 |
| 35197159 | Clinical standards for the diagnosis, treatment and prevention of TB infection. | Int J Tuberc Lung Dis | 2022 |
| 35651519 | Case studies to illustrate good practice in the management of non-tuberculous mycobacterial pulmonary disease. | Respir Med Case Rep | 2022 |
| 35650702 | Clinical standards for the dosing and management of TB drugs. | Int J Tuberc Lung Dis | 2022 |
| 35475873 | Country-specific lockdown measures in response to the COVID-19 pandemic and its impact on tuberculosis control: a global study. | J Bras Pneumol | 2022 |
| 35768923 | Clinical standards for drug-susceptible pulmonary TB. | Int J Tuberc Lung Dis | 2022 |
| 35768917 | WHO drug-resistant TB guidelines 2022: what is new? | Int J Tuberc Lung Dis | 2022 |
| 35378271 | The case for expanding worldwide access to point of care molecular drug susceptibility testing for isoniazid. | Clin Microbiol Infect | 2022 |
| 35505472 | The war in Ukraine and potential consequences for the TB epidemic in Europe. | Int J Tuberc Lung Dis | 2022 |
| 35342000 | Drug resistant TB - latest developments in epidemiology, diagnostics and management. | Int J Infect Dis | 2022 |
| 35364284 | Armed conflict and human displacement may lead to an increase in the burden of tuberculosis in Europe. | Int J Infect Dis | 2022 |
| 35753836 | Breathing Back Better! A State of the Art on the Benefits of Functional Evaluation and Rehabilitation of Post-Tuberculosis and Post-COVID Lungs. | Arch Bronconeumol | 2022 |
| 35626040 | Large-Scale Profiling of Extracellular Vesicles Identified miR-625-5p as a Novel Biomarker of Immunotherapy Response in Advanced Non-Small-Cell Lung Cancer Patients. | Cancers (Basel) | 2022 |
| 35589114 | Rifapentine access in Europe: growing concerns over key tuberculosis treatment component. | Eur Respir J | 2022 |
| 36064681 | COVID-19 Hampered Diagnosis of TB Infection in France, Italy, Spain and the United Kingdom. | Arch Bronconeumol | 2022 |
| 36163667 | Literature Highlights. | Int J Tuberc Lung Dis | 2022 |
| 36223373 | Using ISARIC 4C mortality score to predict dynamic changes in mortality risk in COVID-19 patients during hospital admission. | PLoS One | 2022 |
| 35945071 | Rapid Diagnosis of XDR and Pre-XDR TB: A Systematic Review of Available Tools. | Arch Bronconeumol | 2022 |
| 35227650 | Pulmonary tuberculosis in intensive care setting, with a focus on the use of severity scores, a multinational collaborative systematic review. | Pulmonology | 2022 |
| 35248715 | World TB Day 2022: Revamping and Reshaping Global TB Control Programs by Advancing Lessons learnt from the COVID-19 pandemic. | Int J Infect Dis | 2022 |
| 35124102 | History of prevention, diagnosis, treatment and rehabilitation of pulmonary sequelae of tuberculosis. | Presse Med | 2022 |
| 35245659 | Delamanid-containing regimens and multidrug-resistant tuberculosis: A systematic review and meta-analysis. | Int J Infect Dis | 2022 |
| 35241410 | Investigating the response to COVID-19 and understanding severe TB cases: The 2022 Pulmonology TB series. | Pulmonology | 2022 |
| 35241129 | Enhanced protein isoform characterization through long-read proteogenomics. | Genome Biol | 2022 |
| 35338843 | Optimising tuberculosis care for refugees affected by armed conflicts. | Lancet Respir Med | 2022 |
| 33272908 | Tuberculosis and its future in the COVID-19 era: The Pulmonology series 2021. | Pulmonology | 2021 |
| 35344503 | Malnutrition assessment methods in adult patients with tuberculosis: a systematic review. | BMJ Open | 2021 |
| 33656424 | TB management in the European Union/European Economic Area: a multi-centre survey. | Int J Tuberc Lung Dis | 2021 |
| 33547029 | Tuberculosis and COVID-19 interaction: A review of biological, clinical and public health effects. | Pulmonology | 2021 |
| 33547028 | Tuberculosis, COVID-19 and hospital admission: Consensus on pros and cons based on a review of the evidence. | Pulmonology | 2021 |
| 33716195 | Global Tuberculosis Report 2020 - Reflections on the Global TB burden, treatment and prevention efforts. | Int J Infect Dis | 2021 |
| 33713815 | Accelerating development of new shorter TB treatment regimens in anticipation of a resurgence of multi-drug resistant TB due to the COVID-19 pandemic. | Int J Infect Dis | 2021 |
| 33762068 | Post-TB disease: a new topic for investigation-and why it matters. | Int J Tuberc Lung Dis | 2021 |
| 33737408 | Screening for tuberculosis among high-risk groups attending London emergency departments: a prospective observational study. | Eur Respir J | 2021 |
| 33648891 | Different disease, same challenges: Social determinants of tuberculosis and COVID-19. | Pulmonology | 2021 |
| 33817915 | Diagnostic pitfalls of urogenital tuberculosis. | Trop Med Int Health | 2021 |
| 33617781 | Delayed-onset myocarditis following COVID-19. | Lancet Respir Med | 2021 |
| 33560672 | Atypical mycobacterial infections - management and when to treat. | Curr Opin Pulm Med | 2021 |
| 33753021 | Outcome of treatment of MDR-TB or drug-resistant patients treated with bedaquiline and delamanid: Results from a large global cohort. | Pulmonology | 2021 |